Cikakken Bayani
Sauƙi don tattara samfurori
Sakamakon nan take a minti 15
Babu kayan aiki da ake buƙata
Sakamako a bayyane suke
Mafi kyawun na'urorin gwaji na gaggawa na COVID-19 Antigen AMRDT115
Marufi & Bayarwa
Cikakken bayanin marufi: daidaitaccen fakitin fitarwa Bayanin isarwa: a cikin kwanakin aiki 7-10 bayan an karɓi biyan kuɗi |
Ƙayyadaddun bayanai
Mafi kyawun na'urorin gwaji na gaggawa na COVID-19 Antigen AMRDT115
Wasu bincike na baya-bayan nan sun ba da shawarar rawar yau a cikin gano SARS-CoV-2.Yawancin bincike sun ruwaito cewa babu wani bambanci mai mahimmanci tsakanin nasopharyngeal ko oropharyngeal swab da samfurori na yau da kullum game da kwayar cutar hoto.
Clongene ya haɓaka kaset ɗin gwajin gaggawa na Antigen na COVID-19 (Saliva).COVID-19 Saliva Antigen Rapid Cassette Cassette AMRDT115 immunoassay ne mai gudana a gefe wanda aka yi niyya don gano ƙimar SARS-CoV-2 nucleocapsid antigens a cikin leƙoƙi daga mutanen da ake zargi da COVID-19 ta hanyar mai ba da kiwon lafiya.
Mafi kyawun na'urorin gwaji na COVID-19 Antigen Saurin Gwajin AMRDT115 Siffofin Samfur
Sauƙi don tattara samfurori
Sakamakon nan take a minti 15
Babu kayan aiki da ake buƙata
Sakamako a bayyane suke
Ya dace da babban gwajin saurin dubawa
Mafi kyawun na'urorin gwaji na gaggawa na COVID-19 Antigen AMRDT115 Principle
Gwajin saurin Antigen na COVID-19 (Saliva) rigakafi ne na kwararar ruwa ta gefe bisa ka'idar dabarar sanwici mai cutarwa biyu.Za a iya ganin layin gwaji mai launi (T) a cikin taga sakamakon, idan antigens SARS-CoV-2 suna cikin samfurin.Rashin layin T yana nuna sakamako mara kyau.
Mafi kyawun na'urorin gwajin gaggawa na Antigen na COVID-19 AMRDT115 Halayen Ayyuka
Ayyukan Clinical
Mutum 645 marasa lafiya da alamun bayyanar cututtuka da marasa lafiya asymptomatic waɗanda ake zargi da COVID-19. Samfuran
An gano su ta COVID-19 Antigen Rapid Test da RT-PCR.Sakamakon gwajin ya nuna kamar teburin da ke ƙasa
Mafi kyawun na'urorin gwaji na gaggawa na COVID-19 Antigen AMRDT115
Iyaka na Ganewa (Nazarin Nazari)
Binciken ya yi amfani da kwayar cutar SARS-CoV-2 mai al'ada (Warewa Hong Kong/M20001061/2020, NR-52282), wanda zafi ne a cikin kunnawa kuma ya zuga cikin miya.Iyakar Ganewa (LoD) shine 8.6X100 TCIDso/mL.
Reactivity (Tsarin Nazari)
32 commensal da pathogenic microorganisms wanda zai iya kasancewa a cikin baka an kimanta su, kuma ba a lura da giciye ba.
Tsangwama
An kimanta abubuwa 17 masu yuwuwar tsoma baki tare da maida hankali daban-daban kuma an sami wani tasiri ga aikin gwajin.
Tasirin ƙugiya mai girma
An gwada kaset ɗin gwajin saurin Antigen na COVID-19 har zuwa 1.15X 105 TCIDso / ml na SARS-CoV-2 da ba a kunna ba kuma ba a sami tasirin ƙugiya mai girma ba.